|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||7.10 - 7.33|
|52 Week Range||3.88 - 11.73|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yahoo Finance dives deep into the cannabis industry's rapid expansion and where investors are looking for growth in the space. Join reporters Zack Guzman, Alexis Keenan Weed and Emily McCormick as they interview leaders of some of the biggest cannabis companies and report on what's next for the sector.
The CEOs of the leading marijuana companies have their eyes set on two states to follow Illinois in legalizing recreational marijuana.
After Canopy Growth shares tanked 8% following disappointing earnings, CEO Bruce Linton said he thinks the company will become a leader the CBD market.
After the recent acquisition of Select for $950 million, Curaleaf CEO Joseph Lusardi believes his company is poised to take over the cannabis industry.
At first glance, cannabis and cryptocurrencies seem to have a lot in common. Both comprise highly speculative markets subject to exuberant highs and crushing lows. The legality and regulation of each has languished in the gray. And to many mainstream investors, both have failed to shake synonymy with the black market.
The nascent marijuana industry has made significant strides over the past several years. But the once-illicit marijuana market still has hurdles to cross before unlocking its full potential, according to executives at some of the world’s leading cannabis companies.
By Brendan Bures New Yorkers love to joke about its little brother New Jersey, ribbing any and all of that state’s shortcomings, but the pair are two peas on a pod when it comes to marijuana reform. Just ...
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
Cannabis stocks fell Friday, weighed down by the selloff in the broader market after President Donald Trump opened a new front in his trade war, this time with Mexico, and as a key hearing aimed at creating a regulatory framework for CBD kicked off.
Cannabis operator Curaleaf Holdings, Inc. (CSE:CURA)(OTC: CURLF ) reported first quarter revenue of $75.1 million, a year-to-year increase of 260 percent. Curaleaf opened seven new dispensaries in key ...
Curaleaf Holdings Inc. reported weaker-than-expected revenue and losses that met analyst expectations. The U.S. cannabis company logged first-quarter net losses attributable to Curaleaf of $10.2 million, or 2 cents a share, compared with losses of $2.3 million, or a penny a share, in the year-ago period. Revenue rose to $35.3 million from $9.1 million in the year-ago period. The company reported managed revenue, which the company defines as including revenue from entities that Curaleaf has management contracts, rose sequentially to $40.7 million from $34.9 million in the fourth quarter. The three analysts polled by FactSet estimated first-quarter losses of 2 cents a share and four analysts polled by FactSet modeled revenue of $37.5 million. For the second quarter, analysts model losses of a penny a share on revenue of $62.3 million. Curaleaf stock has gained 14% in the past three months, with the S&P 500 index falling less than 0.1%. Curaleaf stock closed down 2.6% during the regular session Thursday.
STORRS, Conn., May 28, 2019 /PRNewswire/ -- Curaleaf Holdings, Inc. (CURA.CN) (CURLF), a leading vertically integrated cannabis operator in the United States, announced it is sponsoring pioneering industrial hemp research being conducted by the University of Connecticut. The goal of the research is to help improve industrial hemp production levels and advance current cultivation processes. Findings have the potential to impact production in the medical cannabis industry.
WAKEFIELD, Mass., May 21, 2019 /PRNewswire/ -- Curaleaf Holdings, Inc. (CURA.CN) (CURLF) ("Curaleaf"), a leading vertically integrated cannabis operator in the United States, today announced it has acquired exclusive rights to operate the Emerald dispensary in Gilbert, AZ, whose license is held by Absolute Healthcare, Inc., an Arizona non-profit corporation. The dispensary will be rebranded as Curaleaf after the transaction closes. It is one of Arizona's largest and longest standing medical cannabis retailers, serving over 44,000 unique patients since 2014.